Biden-Harris Transition announces COVID-19 Advisory Board

Washington DC – Leading public health and scientific experts to advise the transition to COVID-19 response

The Biden-Harris transition today announced the establishment of the Transition COVID-19 Advisory Board, a team of leading public health experts that will include President-elect Biden, Vice President Harris, and Transition COVID-19 staff advise. The Transition COVID-19 Advisory Board is chaired by co-chairs David Kessler, Drs. Vivek Murthy and Marcella Nunez-Smith. Dr. Beth Cameron and dr. Rebecca Katz serves as advisors for the transition to COVID-19 and will work closely with the Advisory Board.

“Dealing with the coronavirus pandemic is one of the most important battles our government will face, and I will be informed by science and experts,” Biden said. ‘The advisory board will help shape my approach to dealing with the increase in reported infections; to ensure that vaccines are distributed safely, effectively and efficiently, fairly and free of charge; and the protection of dangerous populations. ”

New cases are increasing in at least 40 states, with more than 9.3 million total infections and more than 236,000 deaths. Elected President Biden has vowed to bring leadership to the COVID pandemic, which continues to claim thousands of lives each week, by limiting the spread of the disease, providing free treatment to those in need and raising the voices of scientists and public health experts increase. . The COVID-19 advisory board will help lead the Biden-Harris transition in planning the president’s strong federal response. These leading public health scientists and experts will consult with government officials and local officials to determine what the necessary public health and economic steps are to bring the virus under control, to provide immediate relief to working families, to ensure ongoing racial and ethnic to address inequalities and to make our schools and businesses safe and effective.

The Transition COVID-19 Advisory Board consists of a diverse and experienced group of physicians and scientists. Members of the Advisory Council have served in previous administrations and have experience in responding to and leading our country’s response to nationwide and global public health crises.

Co-chairs and advisory board members:

COSTS

Dr. David Kessler
David A. Kessler, MD, is Professor of Pediatrics and Epidemiology and Biostatistics at UCSF. Dr. Kessler served from 1990 to 1997 as FDA commissioner, appointed by President George HW Bush and reappointed by President Bill Clinton.

Dr Vivek Murthy
Vivek Murthy, MD, MBA, was the 19th Surgeon General of the United States from 2014-2017. As the Vice Admiral of the US Public Corps, he commanded a uniformed service of 6,600 public health officials worldwide. The officials focused on helping underprivileged populations, protecting the country from Ebola and Zika, responding to the Flint water crisis and natural disasters such as hurricanes.

Dr Marcella Nunez-Smith
Marcella Nunez-Smith, MD, MHS, is an Associate Professor of Internal Medicine, Public Health and Management at Yale University and the Associate Dean for Health Equality Research at the Yale School of Medicine. Dr. Nunez-Smith’s research focuses on the promotion of health and health care for structures that are marginalized.

MEMBERS

Dr Luciana Borio
Luciana Borio, managing director, is VP, technical staff at In-Q-Tel. She is also a Senior Fellow for Global Health at the Council on Foreign Relations. Dr. Borio specializes in bio-defense, emerging infectious diseases, medical product development and complex public health emergencies. She has served in senior leadership positions at the FDA and the National Security Council, including as Assistant Commissioner for Terrorism Policy and Acting Chief Scientist at the FDA, and Director of the FDA’s Office for Combating Terrorism and Emerging Threats.

Dr Rick Bright
Rick Bright, PhD, is an American immunologist, virologist and former public health official. Dr. Bright was the Director of the Biomedical Advanced Research and Development Authority (BARDA) from 2016 to 2020 and the Deputy Assistant Secretary for Preparedness and Response at the Department of Health and Human Services. He also previously served as an adviser to the World Health Organization and the U.S. Department of Defense. His career has focused on vaccine, drug and diagnostic development to address emerging infectious diseases and national security threats.

Dr. Ezekiel Emanuel
Ezekiel J. Emanuel, MD, PhD, is an oncologist and vice president for global initiatives and chair of the Department of Medical Ethics and Health Policy at the University of Pennsylvania. From January 2009 to January 2011, he served as Special Adviser on Health Policy to the Director of the White House’s Office of Management and Budget. Since 1997, he has chaired the Department of Bioethics at The Clinical Center of the National Institutes of Health (NIH).

Dr. Atul Gawande
Atul Gawande, MD, MDH, is the Cyndy and John Fish Professor of Surgery at Brigham and Women’s Hospital, Samuel O. Thier, Professor of Surgery at Harvard Medical School, and Professor of Health Policy and Management at Harvard TH Chan School of Public Health. . Dr. Gawande is also the founder and chairman of Ariadne Labs, a joint center between Brigham and Women’s Hospital and the Harvard TH Chan School of Public Health for health system innovation, and Lifebox, a non-profit organization that makes surgery safer worldwide. He previously served as a senior adviser in the Department of Health and Human Services in the Clinton administration.

Dr. Celine Gounder
Celine Gounder, MD, ScM, FIDSA is a clinical assistant professor at the NYU Grossman School of Medicine and patient care at the Bellevue Hospital Center. From 1998 to 2012, dr. Gounder studied TB and HIV in South Africa, Lesotho, Malawi, Ethiopia and Brazil. While at Johns Hopkins Faculty, dr. Gounder the director of delivery of the consortium funded by the Gates Foundation to respond effectively to the AIDS / TB epidemic. She later served as assistant commissioner and director of the Bureau of Tuberculosis Control at the NYC Department of Health and Mental Hygiene.

Dr Julie Morita
Julie Morita, MD, is executive vice president of the Robert Wood Johnson Foundation (RWJF). Morita previously served nearly two decades as health commissioner for the city of Chicago. She is a member of the American Academy of Pediatrics and has served on many state, local, and national health committees, including the CDC’s Advisory Committee on Immunization Practices and the National Academy of Sciences’ Committee for Community-Based Solutions to Promote Health Equality. the United States.

Dr Michael Osterholm
Michael Osterholm, PhD, MPH, is Professor of Regents, Chairman of McKnight Presidential Public Health and Director of the Center for Research and Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota. Dr. Osterholm previously served as a scientific envoy for health safety on behalf of the State Department. For 24 years (1975 to 1999) he worked in the Minnesota Department of Health; for the past 15 years as a state epidemiologist.

Me Loyce Pace
Loyce Pace, MPH, is the executive director and president of the Global Health Council. Over the course of her career, Loyce has advocated for policies for access to essential medicine and health services worldwide. Me. Pace has worked with Physicians for Human Rights and Catholic Aid Services, and previously served in leadership positions at the LIVESTRONG Foundation and the American Cancer Society.

Dr Robert Rodriguez
Dr. Robert Rodriguez graduated from Harvard Medical School and currently serves as Professor of Emergency Medicine at the UCSF School of Medicine, where he works at the forefront of the emergency department and ICU of two major trauma centers. He has authored more than 100 scientific publications and led national research teams to investigate a range of topics in medicine, including the impact of the COVID-19 pandemic on the mental health of precursors. In July 2020, Dr. Rodriguez offered to help with a critical boost to COVID-19 patients at the ICU in his hometown of Brownsville, Texas.

Dr. Eric Goosby
Eric Goosby, MD, is an internationally recognized infectious disease expert and professor of medicine at the UCSF School of Medicine. During the Clinton administration, dr. Goosby is the founding director of the Ryan White CARE Act, the largest federally funded HIV / Aids program. He then became the interim director of the White House’s Office for National Aids Policy. In the Obama administration, Dr. Goosby appointed Ambassador at large and implements the US President’s Emergency Plan for Aids Relief (PEPFAR). After serving as the US Global Aids Coordinator, he was appointed by the UN Secretary – General as the Special Envoy for TB.

Source:

Leave a Reply

Your email address will not be published.